Once systemic disease is in remission, it is prudent to recognize the importance of alopecia in the patient’s overall sense of well-being and quality-of-life clinical outcome. Scarring alopecia (scalp discoid lupus erythematosus) can be the presenting manifestation of lupus in more than half of affected individuals. Diffuse nonscarring alopecia in lupus is usually responsive to treatment of the systemic disease. Severe, often intractable burning pruritus of the scalp is a frequent complaint in dermatomyositis. Lichen planopilaris may mimic other autoimmune forms of scarring alopecia. Alopecia can also be caused by medications used to treat systemic autoimmune disease and fibromyalgia.
Key Points
- •
Once systemic disease is in remission, it is prudent to recognize the importance of alopecia in the patient’s overall sense of well-being and quality-of-life clinical outcome.
- •
Scarring alopecia (scalp discoid lupus erythematosus) can be the presenting manifestation of systemic lupus erythematosus (SLE).
- •
Diffuse nonscarring alopecia in lupus is ultimately responsive to treatment of the active systemic disease.
- •
Severe, often intractable burning pruritus of the scalp is a frequent complaint in dermatomyositis.
- •
Lichen planopilaris may overlap with or mimic other autoimmune forms of scarring alopecia.
- •
Alopecia can also be caused or aggravated by medications used to treat systemic autoimmune disease and fibromyalgia.
Related posts:
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
